Geftinat 250mg Tablet

Price 4500 INR/ Thousand

Get a Price/Quote

MOQ : 5 Bottles

Geftinat 250mg Tablet Specification

Salt Composition
Gefitinib

Indication
Non-small cell lung carcinoma (NSCLC)

Dosage Form
Oral tablet

Pacakaging (Quantity Per Box)
30 tablets per box

Origin of Medicine
India

Drug Type
Allopathic

Ingredients
Gefitinib 250mg

Physical Form
Tablet

Function
Anticancer agent - egfr tyrosine kinase inhibitor

Recommended For
Adults with non-small cell lung cancer (NSCLC)

Dosage
As directed by the oncologist, typically 250 mg once daily

Dosage Guidelines
Swallow whole with water, do not crush or chew

Suitable For
Adults

Quantity
30 tablets

Storage Instructions
Store below 30C, in a dry place, away from sunlight and moisture

ATC Code
L01XE02

Therapeutic Class
Antineoplastic agents

Shelf Life
24 months from date of manufacture

Marketed By
Natco Pharma Ltd.

Route of Administration
Oral

Warning
Not to be used in pregnant or breastfeeding women without medical advice

Colour
White

Prescription Required
Yes

Packing Type
Blister pack in box

About Geftinat 250mg Tablet

Geftinat 250mg Tablet is used in the treatment of non-small cell lung cancer. It is used in patients in which it has spread to other parts of the body, who have abnormal epidermal growth factor receptor (EGFR) genes, and who have not had previous treatment for cancer.Geftinat 250mg Tablet can be taken with or without food, but better to have it same time every day for better results. You should continue to take it as long as your doctor advises for it. The duration of treatment varies according to your need and response to treatment. You should take it exactly as your doctor has advised. Taking it in the wrong way or taking too much can cause very serious side effects. It may take several weeks or months for you to see or feel the benefits but do not stop taking it unless your doctor tells you to.The most common side effects of this medicine include nausea, rash, vomiting and weight loss. It may cause severe diarrhea, drink plenty of fluids or consult with your doctor if it bothers you. It makes you sensitive towards sunlight, hence wear protective clothing or use sunscreen while going out. In case you develop ulceration in mouth, changes in your vision, or breathing difficulties than it is better to inform the doctor. Your doctor may advise for regular monitoring of liver function while you are taking this medicine.Many other medicines can affect, or be affected by, this medicine so let your healthcare team know all medications you are using. This medicine is not recommended during pregnancy or while breastfeeding. The use of effective contraception by both males and females during treatment is important to avoid pregnancy. If you have to take an antacid or any other medicine, take it at a gap of at least 2 hours after taking the cancer medicine.

Targeted Cancer Therapy

Geftinat 250mg Tablet is specifically designed for the treatment of non-small cell lung carcinoma (NSCLC) in adults. As an EGFR tyrosine kinase inhibitor, it targets the growth and spread of cancer cells, offering a tailored approach to cancer management that may improve outcomes in appropriate patients.

How to Use Geftinat

The recommended dose for Geftinat 250mg Tablet is usually one tablet taken orally every day, as directed by your oncologist. Swallow the tablet whole with water-do not crush or chew it. Maintain consistent daily dosing for optimal therapeutic effect. Always follow your doctor's instructions regarding dosage.

Safe Storage and Handling

To preserve Geftinat's potency, store the tablets below 30C in a dry place, away from sunlight and moisture. The medicine's shelf life is 24 months from the manufacturing date. Keep it out of reach of children and do not use the tablets past their expiry date.

FAQ's of Geftinat 250mg Tablet:

Q: How should I take Geftinat 250mg Tablet for best results?

A: Take Geftinat 250mg Tablet exactly as prescribed by your oncologist, typically one tablet once daily. Swallow the tablet whole with water, and do not crush or chew it. Consistent daily administration helps maintain the effectiveness of the treatment.

Q: What is the primary benefit of using Geftinat 250mg Tablet?

A: Geftinat 250mg Tablet is designed to target non-small cell lung cancer (NSCLC) by inhibiting the EGFR tyrosine kinase enzyme, thereby slowing the growth of cancer cells. It is a targeted therapy that may improve disease management in suitable patients.

Q: Who can use Geftinat 250mg Tablet?

A: Geftinat is recommended for adult patients diagnosed with non-small cell lung carcinoma (NSCLC) and should only be used under the supervision of an oncologist. It is not recommended for children and should not be used by pregnant or breastfeeding women without medical advice.

Q: When should this medication not be used?

A: Avoid Geftinat during pregnancy or breastfeeding unless specifically advised by your physician. It should not be taken by individuals allergic to Gefitinib or any component of the tablet.

Q: Where should Geftinat 250mg Tablets be stored?

A: Store the tablets below 30C, in a dry place, and keep them away from direct sunlight and moisture. It is important to keep Geftinat out of reach of children and pets.

Q: What is the shelf life and packaging of Geftinat 250mg Tablet?

A: Geftinat tablets have a shelf life of 24 months from the date of manufacture. They are packaged in blister packs, with 30 tablets per box for convenience and safety.

Q: How does Geftinat 250mg Tablet work in cancer treatment?

A: Geftinat works by inhibiting the epidermal growth factor receptor (EGFR) pathway, which is often mutated or overexpressed in NSCLC. This targeted action helps prevent the proliferation of cancer cells and may slow disease progression.

Tell us about your requirement